Outcome of children with B cell lymphoma in Venezuela with the LMB-89 protocol

Pediatric Blood and Cancer

Volumn 43, Issue 5, 2004, Pages 580-586

  Acquatella, G ^a   Insausti, C L ^b   Garcia R ^c   Gomez R ^d   Hernandez M ^e   Carneiro, M ^f   Santos, S ^g   Nouel, A ^h  

^a Edificio Centro Los Cortijos ^*  (Venezuela)

^b HOSPITAL UNIVERSITARIO DE CARACAS   (Venezuela)

^c Hospital Dr Domingo Luciani   (Venezuela)

^d Thoracic Oncology Section   (Venezuela)

^e Unidad Transplante Medula Osea   (Venezuela)

^f IVSS Hospital Raul Leoni   (Venezuela)

^g Hospital de Ninos J M de los Rios   (Venezuela)

^h Hospital Ruiz y Paez   (Venezuela)

Author keywords

Chemotherapy; Childhood cancer; LMB 89 protocol; Non Hodgkins lymphoma

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; ETOPOSIDE; FOLINIC ACID; HYDROCORTISONE; METHOTREXATE; PREDNISONE; VINCRISTINE; VINCRISTINE SULFATE; XANTHINE OXIDASE;

ADOLESCENT; ARTICLE; B CELL LYMPHOMA; BURKITT LYMPHOMA; CANCER MORTALITY; CANCER REGRESSION; CANCER SURVIVAL; CHILD; CHILDHOOD CANCER; CLINICAL PROTOCOL; CONTROLLED STUDY; DISEASE COURSE; FEBRILE NEUTROPENIA; HEPATITIS B; HEPATITIS C; HERPES ZOSTER; HUMAN; LYMPHOCYTOMA; MAJOR CLINICAL STUDY; NEUTROPENIA; PRIORITY JOURNAL; THROMBOCYTOPENIA; TUMOR LYSIS SYNDROME; VACCINATION; VENEZUELA; VIRUS INFECTION;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CYCLOPHOSPHAMIDE; CYTARABINE; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; DOXORUBICIN; ETOPOSIDE; FEMALE; HEPATITIS B; HEPATITIS B VACCINES; HUMANS; HYDROCORTISONE; LEUCOVORIN; LYMPHOMA, B-CELL; LYMPHOMA, NON-HODGKIN; MALE; METHOTREXATE; PREDNISONE; RECURRENCE; TREATMENT OUTCOME; VENEZUELA; VINCRISTINE;

EID: 4744372563     PISSN: 15455009     EISSN: None     Source Type: Journal    
DOI: 10.1002/pbc.20116     Document Type: Article

References (28)

1. Murphy SB. Classification staging and end results of treatment of childhood non-Hodgkin's lymphomas: Dissimilarities from lymphomas in adults. Semin Oncol 1980;7:329-332.
2. Acquatella G, Urdaneta N, Rosas Uribe A, et al. Linfoma no-Hodgkin en niños. Experiencia de 30 pacientes en el Hospital Universitario de Caracas. Sangre (España) 1985;30:253-283.
3. Wollner N, Burchenal JH, Lieberman PH, et al. Non-Hodgkin's lymphoma in children. A comparative study of two modalities of therapy. Cancer 1976;37:123-134.
4. 2 en 30 pacientes Unidad de Linfomas, Hospital Universitario de Caracas. Cancerología (México) 1991;37:1355-1359.
5. Insausti CL, Acquatella G, Briceño L, et al. Linfomas en niños. Revisión de la Literatura Nacional. Gac Med Caracas 1995;3:208-212.
6. 2). N Engl Med 1983;308:559-565.
7. Patte C, Philip T, Rodary C, et al. High survival rate in advanced-stage B cell lymphoma and leukemia without CNS involvement with a short intensive polychemotherapy: Results from the SFOP of a randomized trial of 216 children. J Clin Oncol 1991;9:123-132.
8. 2 protocol with high dose Methotrexate on 84 children with non-B cell (lymphoblastic lymphoma). Med Pediatr Oncol 1992;20:105-113.
9. Patte C, Auperin A, Michon J, et al. The Sociéte Francaise d'Oncologie Pédiatrique (SFOP) LMB-89 protocol: Highly effective multiagent chemotherapy tailored to the tumor burden and initial response in 561 unselected children with B-cell lymphomas and L3 leukemia. Blood 2001;97:3370-3379.
10. Peto R, Pike MC, Armitage P, et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient, II: Analysis and examples. Br J Cancer 1997;35:1-39.
11. Kaplan GL, Meier P. Non parametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-463.
12. Perera A, Navarro C, Ramírez F, et al. Análisis de 32 niños con Leucosis Linfoblástica Aguda. Acta Odontol Venez 1987;20:49-63.
13. Tanaka J, Hepatitis B. Epidemiology in Latin America. Vaccine 2000;18(Suppl 1):S17-S19.
14. Berberoglu S, Buyukpamuckeu M, Sarialoglu F, et al. Hepatitis B vaccination in children with cancer. Pediat Hematol Oncol 1995;12:171-178.
15. Meral A, Sevinir B, Gunay U. Efficacy of immunization against hepatitis B virus infection in children with cancer. Med Pediat Oncol 2000;35:47-51.
16. Sandlund JT, Doroming JR, Crist WM. Non-Hodgkin's lymphoma in childhood. NEJM 1996;334:1238-1248.
17. Insausti CL, Acquatella G, García Guevara R, et al. Linfoma no-Hodgkin en niños. Experiencia de 25 años de tratamiento en Venezuela. Rev Chil Cancerol Hematol 2002;12:25-35.
18. Lara CC, Rosas-Uribe A. Tumores pediátricos linfohematopoyé ticos malignos: Características clínicas y patológicas en 127 pacientes. Patología (España) 1992;25:205-216.
19. Cárdenas Cardós R, Rivera LR, Martínez Agreda R, et al. Análisis comparativo de 3 regímenes de tratamiento en niños con linfoma de Burkitt. Oncología (México) 2001;3:40-45.
20. Pereira A, Martínez-Siso M, Machado AC, et al. Tumores sólidos en niños, experiencia del Hospital de Niños. J. M de los Ríos. Caracas, Venezuela. Rev Venez Oncol 1997;9:64-75.
21. Murphy SB. Biology and therapy of B-cell lymphoma in children: Are there lessons applicable to adult B-Cell lymphoma? ASCO 2001 Educ Book 2001; 247-251.
22. Hutchison RE, Berard CW, Shuter JJ, et al. B-cell lineage confers a favorable outcome among children and adolescent with large-cell lymphoma: Pediatric Oncology Group Study. J Clin Oncol 1995;13:2023-2032.
23. Patte C, Sakiroglu O, Sommelet D. European experience in the treatment of hyperuricemia. Sem Hematol 2001;38:9-12.
24. Santos S, Pereira A, Ariza M, et al. Síndrome de Lisis Tumoral en Pacientes Pediátricos con Linfoma tipo Burkitt. Rev Venez Oncol 2003;15(1):38-44.
25. Pui CH. Urate-oxydase in the prophylaxis or treatment of hyperuricemia: The United States experience. Sem Hematol 2001;38:13-21.
26. Kobrinsky NL, Sposto R, Shah NR, et al. Outcomes of treatment of children and adolescents with recurrent non-Hodgkin's lymphoma and Hodgkin's disease with dexamethasone, etoposide, cisplatin, cytarabine, and 1-asparaginase, maintenance chemotherapy, and transplantation: Children's Cancer Group Study CCGS-5912. J Clin Oncol 2001;19:2390-2396.
27. Patte C, Gerrard M, Aupin A, et al. Results of the randomised international trial FAB LMB-96 for the "intermediate risk" childhood and adolescent B-cell lymphoma: Reduce therapy is efficacious. Proc Am Soc Oncol 2003;22:796 (Abstract 3198).
28. Fay OH. Hepatitis B in Latin America: Epidemiological patterns and eradication strategy. The Latin American Regional Study Group. Vaccine 1990;8(Suppl):S100-S106.